Åsa Konradsson Geuken

Publikationer
CV
Populärvetenskap och samverkan

Artiklar

Article: JOURNAL OF NEURAL TRANSMISSION. 2015;122(2):259-272

Deuterium-substituted L-DOPA displays increased behavioral potency and dopamine output in an animal model of Parkinson's disease: comparison with the effects produced by L-DOPA and an MAO-B inhibitor.

Malmlöf T; Feltmann K; Konradsson-Geuken Å; Schneider F; Alken R-G; Svensson TH; Schilström B
Article: INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY. 2014;18(3):pyu068

Adjunctive treatment with asenapine augments the escitalopram-induced effects on monoaminergic outflow and glutamatergic neurotransmission in the medial prefrontal cortex of the rat.

Björkholm C; Frånberg O; Malmerfelt A; Marcus MM; Konradsson-Geuken Å; Schilström B; Jardemark K; Svensson TH
Article: INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY. 2013;16(9):2041-2051

Hippocampal and prefrontal dopamine D1/5 receptor involvement in the memory-enhancing effect of reboxetine.

De Bundel D; Femenía T; DuPont CM; Konradsson-Geuken Å; Feltmann K; Schilström B; Lindskog M
Article: SYNAPSE. 2012;66(4):277-290

Augmentation by escitalopram, but not citalopram or R-citalopram, of the effects of low-dose risperidone: behavioral, biochemical, and electrophysiological evidence.

Marcus MM; Jardemark K; Malmerfelt A; Gertow J; Konradsson-Geuken A; Svensson TH
Article: SYNAPSE. 2011;65(5):357-367

Effects of S-citalopram, citalopram, and R-citalopram on the firing patterns of dopamine neurons in the ventral tegmental area, N-methyl-D-aspartate receptor-mediated transmission in the medial prefrontal cortex and cognitive function in the rat.

Schilström B; Konradsson-Geuken A; Ivanov V; Gertow J; Feltmann K; Marcus MM; Jardemark K; Svensson TH
Article: NEUROSCIENCE. 2010;169(4):1848-1859

Cortical kynurenic acid bi-directionally modulates prefrontal glutamate levels as assessed by microdialysis and rapid electrochemistry.

Konradsson-Geuken A; Wu HQ; Gash CR; Alexander KS; Campbell A; Sozeri Y; Pellicciari R; Schwarcz R; Bruno JP
Article: INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY. 2010;13(7):891-903

Adjunctive alpha2-adrenoceptor blockade enhances the antipsychotic-like effect of risperidone and facilitates cortical dopaminergic and glutamatergic, NMDA receptor-mediated transmission.

Marcus MM; Wiker C; Frånberg O; Konradsson-Geuken A; Langlois X; Jardemark K; Svensson TH
Article: SYNAPSE. 2009;63(12):1069-1082

Second-by-second analysis of alpha 7 nicotine receptor regulation of glutamate release in the prefrontal cortex of awake rats.

Konradsson-Geuken A; Gash CR; Alexander K; Pomerleau F; Huettl P; Gerhardt GA; Bruno JP
Article: SYNAPSE. 2009;63(10):913-920

Differential effects of topiramate on prefrontal glutamatergic transmission when combined with raclopride or clozapine.

Jardemark KE; Konradsson A; Schilström B; Marcus MM; Svensson TH
Article: PSYCHOPHARMACOLOGY. 2008;196(3):417-429

Asenapine, a novel psychopharmacologic agent: preclinical evidence for clinical effects in schizophrenia.

Frånberg O; Wiker C; Marcus MM; Konradsson A; Jardemark K; Schilström B; Shahid M; Wong EHF; Svensson TH
Article: SYNAPSE. 2006;60(2):102-108

Inhibition of the glycine transporter GlyT-1 potentiates the effect of risperidone, but not clozapine, on glutamatergic transmission in the rat medial prefrontal cortex.

Konradsson A; Marcus MM; Hertel P; Svensson TH; Jardemark KE
Article: INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY. 2005;8(2):157-162

The combination of nicotine with the D2 antagonist raclopride or the weak D4 antagonist L-745,870 generates a clozapine-like facilitation of NMDA receptor-mediated neurotransmission in pyramidal cells of the rat medial prefrontal cortex.

Jardemark K; Marcus MM; Konradsson A; Svensson TH

Alla övriga publikationer

Meeting abstract: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2009;19:S562-S563

Enhanced cortical dopaminergic and glutamatergic transmission and antipsychotic-like effect of risperidone by idazoxan

Marcus MM; Wiker C; Franberg O; Konradsson-Geuken A; Langlois X; Jardemark K; Svensson TH
Meeting abstract: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2007;17:S477

Asenapine:: preclinical evidence for clinical effects in schizophrenia and cognitive dysfunction

Svensson TH; Frånberg O; Konradsson A; Jardemark K; Schilstroem B; Wiker C; Ivanov V; Shahid M; Wong EHF; Marcus MM
Meeting abstract: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2007;17:S33-S34

Adjuvant treatment with the anticonvulsant drug topiramate in schizophrenia

Konradsson A; Marcus MM; Sitzia R; Svensson TH; Jardemark KE
Meeting abstract: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2007;17:S20-S21

Asenapine: preclinical evidence for clinical effects in Schizophrenia

Franberg O; Marcus MM; Konradsson A; Jardemark K; Schilstrom B; Wiker C; Shahid M; Wong EHF; Svensson TH
Meeting abstract: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2006;16:s30-s31

Inhibition of glycine uptake augments risperidone's effect on prefrontal glutamatergic transmission

Konradsson A; Marcus MM; Hertel P; Svensson TH; Jardemark KE
Meeting abstract: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2003;13:s301

Addition of nicotine to the D₂ antagonist raclopride or the weak D₄ antagonist L-745,870 augments NMDA-induced currents in pyramidal cells from the rat medial prefrontal cortex

Marcus MM; Jardemark KE; Konradsson Å; Svensson TH

Anställningar

Anknuten till Forskning, Fysiologi och farmakologi, Karolinska Institutet, 2023-2024

Examina och utbildning

MEDICINE DOKTORSEXAMEN, Institutionen för fysiologi och farmakologi, Karolinska Institutet, 2007
Medicine Kandidatexamen, Karolinska Institutet, 2001
Biomedicinsk Analytikerexamen, Karolinska Institutet, 2001

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI